X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-08-12 | EMBC | Kurdikar Devdatt | Pres, CEO | P - Purchase | $4.70 | +30,000 | 804,919 | +4% | +$140,937 | ||||||
2026-08-12 | EMBC | Elguicze Jacob | SVP, CFO | P - Purchase | $4.67 | +20,000 | 309,139 | +7% | +$93,360 | ||||||
2026-08-12 | EMBC | Mann Jeffrey Z | Pres, Pharm Svc, Prod Mgmt, CL | P - Purchase | $4.99 | +20,000 | 262,915 | +8% | +$99,800 | ||||||
2026-08-12 | EMBC | Hombach Robert J. | Dir | P - Purchase | $4.97 | +45,000 | 109,587 | +70% | +$223,848 | ||||||
2025-05-23 | EMBC | Melcher David F | Dir | P - Purchase | $10.60 | +10,000 | 86,681 | +13% | +$105,995 | ||||||
2025-02-25 | EMBC | Melcher David F | Dir | P - Purchase | $13.67 | +13,000 | 76,681 | +20% | +$177,646 | ||||||
2025-02-13 | EMBC | Morris Milton Mayo | Dir | S - Sale | $16.38 | -3,100 | 36,133 | -8% | -$50,783 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |